1. Mottet N, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. Presented at: European Association of Urology Annual Congress; April 11–15, 2014; Stockholm, Sweden.
2. Garcia-Albeniz X, Chan JM, Paciorek AT, et al. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse [abstract 5003]. J Clin Oncol 2014;32(Suppl):5s.
3. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial;Warde;Lancet,2011
4. Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials;Sciarra;Eur Urol,2013
5. Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix;Crawford;Urology,2014